The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Open accessAbstract
Inflammasomes are involved in diverse inflammatory diseases, so the activation of inflammasomes needs to be tightly controlled to prevent excessive inflammation. However, the endogenous regulatory mechanisms of inflammasome activation are still unclear. Here, we report that the neurotransmitter dopamine (DA) inhibits NLRP3 inflammasome activation via dopamine D1 receptor (DRD1). DRD1 signaling negatively regulates NLRP3 inflammasome via a second messenger cyclic adenosine monophosphate (cAMP), which binds to NLRP3 and promotes its ubiquitination and degradation via the E3 ubiquitin ligase MARCH7. Importantly, in vivo data show that DA and DRD1 signaling prevent NLRP3 inflammasome-dependent inflammation, including neurotoxin-induced neuroinflammation, LPS-induced systemic inflammation, and monosodium urate crystal (MSU)-induced peritoneal inflammation. Taken together, our results reveal an endogenous mechanism of inflammasome regulation and suggest DRD1 as a potential target for the treatment of NLRP3 inflammasome-driven diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, NLRP3−/− mice were resistant to the loss of nigral dopaminergic neurons induced by treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and this was associated with a reduction in caspase-1 activation and IL-1β and IL-18 secretion (244).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [244]
Citations
Cites
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,401
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,000
Zhao, X., Pu, D.-B., Zhao, Z., Zhu, H., Li, H., Shen, Y., Zhang, X., Zhang, R., Shen, J., Xiao, W., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00565 · Cited by 18
Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
McCallum, R. T., & Perreault, M. L. (2021) · Cells · doi:10.3390/cells10092270 · Cited by 19
Zhu, H. B., Zhang, L., Xiao, F., Wu, L., Guo, Y., Zhang, Z., Xiao, Y., Sun, G., Yang, Q., & Guo, H. (2023) · Inflammation · doi:10.1007/s10753-023-01822-5 · Cited by 19
Liu, Q., Tong, L., Chen, M., Wang, P., Luo, E., Liang, J., Zhang, X., Fan, Y., & Sun, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202304308 · Cited by 18
Brand-Rubalcava, P. A., Tejeda-Martínez, A. R., González‐Reynoso, O., Nápoles-Medina, A. Y., Chaparro-Huerta, V., & Flores-Soto, M. E. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105906 · Cited by 18
Xi, X., Zhang, R., Chi, Y., Zhu, Z., Sun, R., & Gong, W. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04089-5 · Cited by 18
Decoding the specificity of m6A RNA methylation and its implication in cancer therapy
Cun, Y., Guo, W., Ma, B., Okuno, Y., & Wang, J. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.035 · Cited by 17
Avila, J. A., Zanca, R. M., Shor, D., Paleologos, N., Alliger, A. A., Figueiredo‐Pereira, M. E., & Serrano, P. A. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00509 · Cited by 18
Kawano, M., Saika, K., Takagi, R., Matsui, M., & Matsushita, S. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100071 · Cited by 18
Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation
Beesetti, S. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25970 · Cited by 18
Xu, W., Ma, W., Yue, J., Hu, Y., Zhang, Y., Wang, H., Tai, S., Chen, J., & Liang, C. Y. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156732 · Cited by 17
Effects of exercise on neuroinflammation in age-related neurodegenerative disorders
Su, Y., & Su, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-03165-3 · Cited by 22
Calovi, S., Mut-Arbona, P., Tod, P., Iring, A., Nicke, A., Mato, S., Vizi, E. S., Tønnesen, J., & Sperlágh, B. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.566251 · Cited by 18
Interaction Between the Angiotensin-(1–7) Mas Receptor and the Dopamine D2 Receptor
Mikusic, N. L. R., Silva, M. G., Mazzitelli, L. R., Santos, R. A. S., Gómez, K. A., Grecco, H. E., & Gironacci, M. M. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16614 · Cited by 17
Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity
Prado, C. E., Osorio‐Barrios, F., Falcón, P., Espinoza, A., Sáez, J. J., Yuseff, M.-I., & Pacheco, R. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02338-1 · Cited by 17
Marino, F., Pinoli, M., Rasini, E., Martini, S. D., Luini, A., Pulze, L., Gasperina, D. D., Grossi, P., Legnaro, M., Ferrari, M., et al. (2022) · Immunology · doi:10.1111/imm.13550 · Cited by 17
Human gut microbiota and Parkinson's disease
Pant, A., Bisht, K. S., Aggarwal, S., & Maiti, T. K. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.08.004 · Cited by 17
Wang, X., Zhu, X., Li, X., Li, Z., Mao, Y. Q., Zhang, S., Liu, X., Liu, X., Liu, Y., Cao, F., et al. (2022) · Food & Function · doi:10.1039/d2fo02595g · Cited by 17
Lo, C., Yen, C., Chen, C.-Y., Chen, H., & Lii, C. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116424 · Cited by 17
Functionalized nanomaterials targeting NLRP3 inflammasome driven immunomodulation: Friend or Foe
Kanika, & Khan, R. (2023) · Nanoscale · doi:10.1039/d3nr03857b · Cited by 18
Zhang, Z. H., Li, M., Tai, Y., Xing, Y., Zuo, H., Jin, X., & Ma, J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110979 · Cited by 17
Zhang, C., Zhou, J., Zhuo, L., Zhang, W., Lv, L., Zhu, L., Zhang, J., Feng, F., Liu, W., Han, L., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118391 · Cited by 18
Xu, Z., Yang, L., Chen, H., Liu, S., Li, X., Li, S., Ying, C., Li, X., Du, R. F., & Liu, D. (2024) · Animal nutrition · doi:10.1016/j.aninu.2024.06.005 · Cited by 19
Ghaith, W. Z., Wadie, W., & El-Yamany, M. F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113716 · Cited by 19
Beyer, D. K. E., Mattukat, A., & Freund, N. (2021) · International Journal of Bipolar Disorders · doi:10.1186/s40345-020-00212-2 · Cited by 18
Senso-Immunologic Prospects for Complex Regional Pain Syndrome Treatment
Okumo, T., Takayama, Y., Maruyama, K., Kato, M., & Sunagawa, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.786511 · Cited by 17
Wang, B., Li, X., Li, M., Geng, Y., Wang, N., Jin, Y., Zhang, W., Xu, K., Wang, J., Li, T., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04695-y · Cited by 17
Elimination of GPR 146‐mediated antiviral function through IRF 3/ HES 1‐signalling pathway
Huang, H., Zhang, N., Xiong, Q., Chen, R., Zhang, C., Wang, N., Wang, L., Ren, H., Liu, M., Qian, M., et al. (2017) · Immunology · doi:10.1111/imm.12752 · Cited by 17
Sim, M., Hong, S. H., Jung, M. H., Choi, E. Y., Hwang, G., Shin, D.-M., & Kim, C.-S. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.032 · Cited by 19
Paolis, M. L. D., Loffredo, G., Krashia, P., Barbera, L. L., Nobili, A., Cauzzi, E., Babicola, L., Segni, M. D., Coccurello, R., Puglisi‐Allegra, S., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01736-4 · Cited by 16
Ayabe, T., Fukuda, T., & Ano, Y. (2020) · Biomolecules · doi:10.3390/biom10010131 · Cited by 17
Dopamine inhibits pyroptosis and attenuates secondary damage after spinal cord injury in female mice
Jiang, W., He, F., Ding, G., & Wu, J. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136935 · Cited by 16
An update on the role of TRIM/NLRP3 signaling pathway in atherosclerosis
Liu, S., Bi, H., Jiang, M., Chen, Y., & Jiang, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114321 · Cited by 17
MARCH7-mediated ubiquitination decreases the solubility of ATG14 to inhibit autophagy
Shi, X. F., Wu, W., Feng, Z., Fan, P., Shi, R., & Zhang, X. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113045 · Cited by 15
Shateri, S., Khatami, S. H., Toutounchi, A. H., Rajaei, S., Mahdavi, M., Baram, S. M., Shahidi, G. A., Habibi, A. H., Aghamollaii, V., Ghlichnia, B., et al. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2292951 · Cited by 16
Carrillo-Gálvez, A. B., Zurita, F., Guerra-Valverde, J. A., Aguilar-González, A., Abril‐García, D., Padial‐Molina, M., Olaechea, A., Martín‐Morales, N., Martı́n, F., O’Valle, F., et al. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae042 · Cited by 16
Parrado, A. C., Salaverry, L. S., Mangone, F. M., Apicella, C., Gentile, T., Canellada, A. M., & Rey-Roldán, E. B. (2017) · NeuroImmunoModulation · doi:10.1159/000486241 · Cited by 16
Stutz, B., Nasrallah, C. M., Nigro, M., Curry, D. W., Liu, Z.-W., Gao, X., Elsworth, J. D., Mintz, L., & Horváth, T. L. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.02.005 · Cited by 15
Matt, S. M., Nickoloff-Bybel, E. A., Rong, Y., Runner, K., Johnson, H. S., O'Connor, M. H., Haddad, E. K., & Gaskill, P. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663061 · Cited by 14
Rani, L., Sahu, M. R., & Mondal, A. C. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.007 · Cited by 16
Barbera, L. L., Krashia, P., Loffredo, G., Cauzzi, E., Paolis, M. L. D., Montanari, M., Saba, L., Spoleti, E., Ficchì, S., Zaccone, C., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00893-2 · Cited by 17
Stabilizing MARCH7 as a ferro-guardian against ferroptosis
Huang, W., Wang, R., Yang, X., Yang, S., Yang, X., He, G., Dai, S., Li, C., Gao, L., Zhang, T., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.052 · Cited by 17
Yun, Y., Baek, A., & Kim, D. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.5.211 · Cited by 15
Araújo, F. M. D., Frota, A. F., de Jesus, L. B., Macedo, T. C., Cuenca‐Bermejo, L., Sanchez-Rodrigo, C., Ferreira, K. M. S., de Oliveira, J. V. R., Costa, M. D. F. D., Segura-Aguilar, J., et al. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01173-5 · Cited by 15
Nanda, S. K., Vollmer, S., & Pérez‐Oliva, A. B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.887533 · Cited by 15
Regulation of Pain Perception by Microbiota in Parkinson Disease
Manjarres, Z., Calvo, M., & Pacheco, R. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000674 · Cited by 15
Khawas, S., & Sharma, N. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05062-5 · Cited by 16
Kaur, B., Biby, S., Namme, J. N., More, S., Xu, Y., & Zhang, S. (2024) · Advances in pharmacology · doi:10.1016/bs.apha.2024.10.004 · Cited by 15
Qin, Y., Li, K., Zhang, Q., Liu, J., Xie, Y., Zhang, T., Wang, X., Zhang, L., Yu, J., & Liu, G. (2024) · Journal of Applied Biomedicine · doi:10.32725/jab.2024.023 · Cited by 15
Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis
Karmakar, V., Chain, M., Majie, A., Ghosh, A., Sengupta, P., Dutta, S., Mazumder, P. M., & Gorain, B. (2025) · Inflammopharmacology · doi:10.1007/s10787-024-01629-2 · Cited by 18
Xie, S., Guo, C., Chi, Z., Huang, B., Wu, Y., Wang, D., & Xia, D. (2017) · FEBS Letters · doi:10.1002/1873-3468.12782 · Cited by 15
He, H., Liu, J., Li, L., Gui, Q., Hao, D., Li, M., Zhang, Y., Hong, X., Xu, J., & Yan, D. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000234 · Cited by 15
Bonte, M.-A., Idrissi, F. E., Gressier, B., Devos, D., & Bélarbi, K. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107526 · Cited by 17
Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome
Wang, B., Dai, Z.-H., Gao, Q., Liu, Y., Gu, G., & Zheng, H. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.068 · Cited by 15
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
Chagraoui, A., Giovanni, G. D., & Deurwaerdère, P. D. (2022) · Biomolecules · doi:10.3390/biom12020243 · Cited by 15
Begieneman, M. P. V., ter Horst, E. N., Rijvers, L., Meinster, E., Leen, R., Pankras, J. E., Fritz, J., Kubat, B., Musters, R. J. P., Kuilenburg, A. B. P., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00633.2015 · Cited by 15
Deswaerte, V., Ruwanpura, S. M., & Jenkins, B. J. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.09.023 · Cited by 15
Hao, F., Wang, S., Zhu, X., Xue, J., Li, J., Wang, L., Li, J., Lu, W., & Zhou, T. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2071-5 · Cited by 15
Li, J., Zhang, Y., Ruan, R., He, W., & Qian, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03158-6 · Cited by 18
Deng, F., Yang, D., Qing, L., Chen, Y., Zou, J., Jia, M., Wang, Q., Jiang, R., & Li-hua, H. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00607 · Cited by 19
Chu, X., Zhang, T., Bukhari, I., Hu, M., Xu, J., Yi, X., Liang, X., Zhang, Z., & Zheng, P. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07475-6 · Cited by 15
TRIMs: Generalists Regulating the NLRP3 Inflammasome Signaling Pathway
Deng, N.-H., Zhou, Z., Liu, H., Tian, Z., Wu, Z.-F., Liu, X.-Y., Xiong, W., Zuo, W., & Jiang, Z.-S. (2022) · DNA and Cell Biology · doi:10.1089/dna.2021.0943 · Cited by 14
Cystathionine β-Synthase Suppresses NLRP3 Inflammasome Activation via Redox Regulation in Microglia
Mou, Y.-J., Ma, Y., Yuan, X., Wang, M., Liu, Y., Pei, C., Liu, C., Hou, X., & Hu, L. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0174 · Cited by 14
Jiang, S., Tian, T., Li, W., Liu, T., Wang, C., Hu, G., Du, R., Liu, Y., & Lu, M. (2023) · EMBO Reports · doi:10.15252/embr.202357101 · Cited by 13
Wang, P., Tang, C., Li, J., Huang, X., Jin, R., Yin, F., Liu, Z., Chen, Y., & Zeng, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111194 · Cited by 14
Alipour, S., Mardi, A., Shajari, N., Kazemi, T., Sadeghi, M. R., Heris, J. A., Masoumi, J., & Baradaran, B. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122686 · Cited by 15
YOD1 protects against MRSA sepsis-induced DIC through Lys33-linked deubiquitination of NLRP3
Liu, C., Fan, C., Liu, J., Zhang, S.-Q., Tang, H.-X., Liu, Y., Zhang, S.-Z., Wu, Q., Zhang, J., Qi, Z., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06731-5 · Cited by 15
Liu, X., Fan, T., Guan, J., Luo, A., Yu, Y., Chen, D., Mao, B., Jiang, H., & Liu, W. (2022) · Acupuncture in Medicine · doi:10.1177/09645284221107684 · Cited by 14
Adraoui, F. W., Douw, L., Martens, G. J. M., & Maas, D. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097680 · Cited by 14
Ubiquitination is a major modulator for the activation of inflammasomes and pyroptosis
Jiang, Q., Zhu, Z., & Mao, X. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194955 · Cited by 13
Shen, Y., Guo, X., Han, C., Wan, F. J., Ma, K., Guo, S., Wang, L., Xia, Y. F., Liu, L., Lin, Z., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2549-2 · Cited by 15
The Neuroimmune Communicatome in Inflammation
Olofsson, P. S., Metz, C. N., & Pavlov, V. A. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch59 · Cited by 14
Tumpa, J. J., Hayder, Q. U. A., Maisa, N. S., & Islam, M. N. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1682006 · Cited by 13
Dopamine promotes the progression of AML via activating NLRP3 inflammasome and IL-1β
Wang, H., Zhang, C., Liu, J., Yang, X., Han, F., Wang, R., Zhao, H., Hou, M., & Ma, D. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.07.005 · Cited by 13
Regulation of inflammation and immunity in sepsis by E3 ligases
Shao, S., Zhou, D., Feng, J., Liu, Y., Baturuhu, Yin, H., & Zhan, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124334 · Cited by 13
Inflammasome-Independent Mechanism of NLRP3 is Critical for Platelet GPIb-IX Function and Thrombosis
Chen, X., Li, J., Liu, P., Zhou, Y., Zhang, T., Li, L., Shi, J., Deng, X., Sheng, Y., Chen, W., et al. (2024) · Thrombosis and Haemostasis · doi:10.1055/a-2263-8372 · Cited by 13
SLC25A3 negatively regulates NLRP3 inflammasome activation by restricting the function of NLRP3
Xiao, F., Jia, Y., Zhang, S., Liu, N., Zhang, X., Wang, T., Qiao, J., Yang, G., Che, X., Chen, K., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107233 · Cited by 13
Brandão, W. N., Andersen, M. L., Palermo‐Neto, J., Peron, J. P. S., & Zager, A. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105809 · Cited by 13
Gurram, P. C., Satarker, S., Nassar, A., Mudgal, J., & Nampoothiri, M. (2022) · Chemical Papers · doi:10.1007/s11696-022-02598-y · Cited by 12
Chen, S., Tang, L., Nie, T., Fang, M., & Cao, X. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12582 · Cited by 12
Guan, S., Miao, F., Wang, D., Hu, J., & Wang, H. (2023) · The Journal of Toxicological Sciences · doi:10.2131/jts.48.387 · Cited by 12
Aghelan, Z., Pashaee, S., Abtahi, S. H., Karima, S., Khazaie, H., Ezati, M., & Khodarahmi, R. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10078-7 · Cited by 14
Ha, J., Kim, M., Park, J. S., Lee, Y., Lee, J. Y., Shin, J.-C., Seo, D., Park, S. S., You, J., Jung, S. M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113752 · Cited by 13
Research progress on the roles of dopamine and dopamine receptors in digestive system diseases
Lu, X.-M., Liu, Q., Deng, Y., Wu, J., Mu, X.-Y., Yang, X.-X., Zhang, T., Luo, C., Li, Z., Tang, S., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18154 · Cited by 13
The major histocompatibility complex participates in Parkinson’s disease
Gu, R., Pan, J., Awan, M. U. N., Sun, X., Fang, Y., Bai, L., & Bai, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107168 · Cited by 14
Li, P., Wang, T., Guo, H., Liu, Y., Zhao, H., Ren, T., Tang, Y.-J., Wang, Y., & Zou, M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.073 · Cited by 13
Parkinson’s disease models and death signaling: what do we know until now?
Pedrão, L. F. A. T., Medeiros, P., Leandro, E. C., & Falquetto, B. (2024) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2024.1419108 · Cited by 13
Su, K., Tang, M., Wu, J., Ye, N., Jiang, X., Zhao, M., Zhang, R., Cai, X., Zhang, X., Lin, L., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117476 · Cited by 12
Matt, S. M., Nolan, R., Manikandan, S., Agarwal, Y., Channer, B., Oteju, O., Daniali, M., Canagarajah, J., LuPone, T., Mompho, K., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03403-9 · Cited by 14
Saloner, R., Marquine, M. J., Sundermann, E. E., Hong, S., McCutchan, J. A., Ellis, R. J., Heaton, R. K., Grant, I., & Cherner, M. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002083 · Cited by 12
Liu, X., Zheng, L., Fan, Y., Shen, Q.-Y., Yao, Q., Li, G., Sun, Q., Zhang, Y., Feng, X., & Zhu, J. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00385.2021 · Cited by 12
Lin, M., Jin, Y., Wang, F., Meng, Y., Huang, J., Qin, X., & Fan, Z. (2023) · Pancreas · doi:10.1097/mpa.0000000000002225 · Cited by 12
Catechol-O-methyltransferase gene polymorphism and vulvar pain in women with vulvodynia
Patanwala, I. Y., Lamvu, G., Ledger, W. J., Witzeman, K. A., Marvel, R. P., Rapkin, A. J., Bongiovanni, A. M., Feranec, J. B., & Witkin, S. S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.020 · Cited by 12
Liu, L., Xu, X., Zhang, N., Zhang, Y., & Zhao, K. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106829 · Cited by 13
Ma, H., Zhu, Y., Zhao, X., Jiang, L., Yang, J., Yang, T., & Liu, W. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02160-7 · Cited by 14
Ahmed, S., Pasam, T., & Afreen, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010486 · Cited by 12
Mussel adhesive protein treatment delivered by microneedling for sensitive skin: A clinical study
Dong, R., Jin, Q., Zhi, J., Luo, Y., Yuan, J., Pi, L., Nan, M., Jin, Z., & Jin, C. (2023) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.15645 · Cited by 11
Chen, C.-S., Lin, C.-F., Chou, Y.-L., Lee, D., Tien, P., Wang, Y.-C., Chang, C., Lin, E., Chen, J. J., Wu, M.-Y., et al. (2023) · Acupuncture in Medicine · doi:10.1177/09645284231170886 · Cited by 11
Barbera, L. L., Rizzo, C., Camarda, F., Miceli, G., Tuttolomondo, A., & Guggino, G. (2024) · Cells · doi:10.3390/cells13030271 · Cited by 11
Zhang, L., Liu, W., Li, S., Wang, J., Sun, D., Li, H., Zhang, Z., Hu, Y., & Fang, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304365 · Cited by 11
Metadata
- Authors
- Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R.
- Affiliations
- University of Science and Technology of China (CN)
- Beijing Proteome Research Center (CN)
- Corresponding author
- Tian, Zhigang
- Zhou, Rongbin
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 160
- Issue
- 1-2
- Pages
- 62-73
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2084158898
- Cited by
- 1,014
- References
- 49
- Citations by year
- 2026: 59 · 2025: 93 · 2024: 98 · 2023: 103 · 2022: 108 · 2021: 124 · 2020: 112 · 2019: 79 · 2018: 104 · 2017: 66 · 2016: 47 · 2015: 20
- FWCI
- 34.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81222040, 81330078)
- Ministry of Education of the People's Republic of China (20123402110010, 20123402120001)
- National Key Research and Development Program of China (2013CB944904, 2014CB910800)
- Fundamental Research Funds for the Central Universities
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- dopamine, NLRP3 inflammasome, dopamine D1 receptor, cAMP signaling, ubiquitination, inflammasome regulation, systemic inflammation, neuroinflammation, lipopolysaccharide-induced inflammation, peritonitis
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Cyclic AMP, Animals, Autophagy, Carrier Proteins, Dopamine, Inflammation, Mice, Inbred C57BL, Receptors, Dopamine, Signal Transduction, Receptors, Dopamine D1, Neurotransmitter Agents, Mice, Ubiquitination, Inflammasomes, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review